References
- Sampaio SAP, Castro RM, Rivitti EA, Dermatologia bdsica, 3rd edn. Editora Artes Medicas: Sao Paulo, 1983, pp. 219-20, 434–5, 504.
- Grimes PE, Melasmaetiologic and therapeutic considerations. Arch Dermatol (1995) 131: 1453–7.
- Minelli L, An open, non-comparative study to evaluate the efficacy and tolerability of 2% hydroquinone as a depigmenting agent in the treatment of melasma. Rev Bras Med (1998) 55: 351–5.
- Pathak MA, Fitzpatrick TB, Kraus EW, Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol (1986) 15: 894–9.
- Sanchez JL, Vazquez M, A hydroquinone solution in the treatment of melasma. Int J Dermatol (1982) 21: 55–8.
- Penney KB, Smith CJ, Biol MI, Allen JC, Depigmenting action of hydroquinone depends on disruption of fundamental cell processes. J Invest Dermatol (1984) 82: 308–10.
- Kimberly YI, Hart LL, Use of hydroquinone as a bleaching cream. Ann Pharmacother (1993) 27: 592–3.
- Jimbow K, Obata H, Pathak MA, Fitzpatrick TB, Mechanism of depigmentation by hydroquinone. J Inv Dermatol (1974) 62: 436–49.
- Spencer MC, Topical use of hydroquinone for depigmentation. JAMA (1965) 194(9): 962–4.
- Havens MB, Tramposch KM, Hydroquinone inhibits tyrosinase activity by acting as an alternate substrate. J Invest Dermatol (1986) 87: 409.
- Palumbo A, d'Ischia M, Misuraca G, Prota G, Skin depigmentation by hydroquinone: a chemical and biochemical insight. Pigment Cell Res (1992) (suppl 2): 299–303.
- Fisher AA, Hydroquinone uses and abnormal reactions. Cutis (1983) 31: 240–5.
- Engasser PG, Maibach HI, Cosmetics and dermatology: bleaching creams. J Am Acad Dermatol (1981) 5: 143–7.
- Camarasa JG, Baldrich ES, Exogenous ochronosis with allergic contact dermatitis from hydroquinone. Contact Dermatitis (1994) 31: 57–8.
- Fisher AA, Can bleaching creams containing 2% hydroquinone produce leukoderma? J Am Acad Dermatol (1982) 7: 134.
- Romaguera C, Grimalt F, Leukoderma from hydroquinone. Contact Dermatitis (1985) 12: 183.
- Olumide YM, Photodermatoses in Lagos. Int J Dermatol (1987) 26: 295–9.
- Howard KL, Furner BB, Exogenous ochronosis in a Mexican-American woman. Cutis (1990) 45: 180–2.
- Willams H, Skin lightening creams containing hydroquinone. The case for a temporary ban. Br Med J (1992) 305: 903–4.
- Hull PR, Procter PR. The melanocyte: an essential link in hydroquinone-induced ochronosis. J Am Acad Dermatol (1990) 22: 529–31.
- Martin RF, Sanchez JL, Gonzalez et al, Exogenous ochronosis. Puerto Rico Health SciJ (1992) 11: 23–6.
- Engasser PG, Ochronosis caused by bleaching creams. J Am Acad Dermatol (1984) 10: 1072–3.
- Hardwich N, Van Gelder LW, Van der Merwe CA, Van der Merwc MP, Exogenous ochronosis: an epidemiological study. Br J Dermatol (1989) 120: 229–38.
- Tidman MJ, Horton JJ, MacDonald DM, Hydroquinone-induced ochronosis-light and electron-microscopic features. Clin Exp Dermatol (1986) 11: 224–8.
- Markey AC, Black AK, Rycroft RJG, Confetti-like depigmentation from hydroquinone. Contact Dermatitis (1989) 20: 148–9.
- Jordaan HF, Van Niekerk DJT, Transepidermal elimination in exogenous ochronosis a report of two cases. Am J Dermatopathol (1991) 13: 418–24.
- Phillips JI, Isaacson C, Carman H, Ochronosis in black South Africans who used skin lighteners. Am J Dermatopathol (1986) 8: 14–21.
- Jordaan HF, Mulligan RP, Actinic granuloma-like change in exogenous ochronosis: case report. J Cutan Pathol (1990) 17: 236–40.
- Spilker B, Guide to clinical trials. Lippincott-Raven Publishers: Philadelphia and New York, 1996.